About this trial
The rare autoimmune rheumatic diseases (RAIRDs) are life-long multi-system diseases that are life or organ threatening. RAIRDs can impair quality of life similar to chronic diseases such as heart failure. The aim of the study is to explore content and structure of a support programme for people with RAIRDs in focus groups and survey meetings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of a rare rheumatic condition made by hospital doctor or secondary care: including lupus, systemic vasculitis, myositis, Sjogren syndrome (participant self-report)
Ability to give informed consent (with translation support if needed)
Disqualifiers
None
Trial population
Participants will be recruited via NHS Rheumatology sites, local or national registries, community centres, social media and networks for each focus group in Bristol, Weston and Leeds
Trial design
Other
Cross-sectional
Treatments tested in this trial
Non-interventional study
Other interventionThe study will consist of focus groups and a large scale patient survey
Treatment groups
Trial outcomes
Primary outcomes
Self-management/efficacy PROM
This study involves qualitative research. The focus group phase will not include outcome measurements. In the cross-sectional survey participants will be asked two questions about self-management and efficacy descriptively to describe the cohort/people who take part
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of the West of England
Lead sponsor
University of Leeds
Collaborator